Daniele Santini | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Determinants of bone specific metastasis in prostate cancer	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2017
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2017
The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide	CANCER TREATMENT REVIEWS	2017
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma	BRITISH JOURNAL OF CANCER	2017
Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis	SCIENTIFIC REPORTS	2017
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2017
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions	ONCOTARGET	2017
Interplay between SIRT-3, metabolism and its tumor suppressor role in hepatocellular carcinoma	DIGESTIVE DISEASES AND SCIENCES	2017
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy	THE ONCOLOGIST	2017
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. a “real life” retrospective analysis of progression-free (PFS) and overall survival (OS) according to duration of androgen deprivation therapy	JOURNAL OF CLINICAL ONCOLOGY	2016
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies	EXPERT REVIEW OF VACCINES	2016
H2020 and beyond: skip discrepancy between theory and practice of personalized medicine. A position paper by the italian society of personalized medicine	CURRENT PHARMACEUTICAL BIOTECHNOLOGY	2016
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients. A multicenter Italian experience	THE BREAST	2016
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome	ONCOTARGET	2016
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model	ANNALS OF ONCOLOGY	2016
Integrin a5 is an independent prognosis factor and a potential therapeutic target for breast cancer bone metastasis	ANNALS OF ONCOLOGY	2016
M1-polarized macrophages as predictor of poor response to trabectedin treatment in myxoid liposarcoma	JOURNAL OF CLINICAL ONCOLOGY	2016
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in advanced leiomyosarcoma and angiosarcoma	ANNALS OF ONCOLOGY	2016
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in angiosarcoma and leiomyosarcoma	JOURNAL OF CLINICAL ONCOLOGY	2016
Biological effects of cabozantinib on bone microenvironment	JOURNAL OF CLINICAL ONCOLOGY	2016